Evidence map›Paper›PMID 35155379›Full record

ArticleFrontiers in chemistry2021

New Imidazole-Based

M Shaheer Malik, Reem I Alsantali, Qazi Mohammad Sajid Jamal, Zaki S Seddigi, Moataz Morad, Meshari A Alsharif, Essam M Hussein, Rabab S Jassas, Munirah M Al-Rooqi, Zainularifeen Abduljaleel and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Frontiers in medicine · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M Shaheer MalikDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Reem I AlsantaliDepartment of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Qazi Mohammad Sajid JamalDepartment of Health Informatics, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah, Saudi Arabia.
Zaki S SeddigiDepartment of Environmental Health, College of Public Health and Health Informatics, Umm Al-Qura University, Makkah, Saudi Arabia.
Moataz MoradDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Meshari A AlsharifDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Essam M HusseinDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Rabab S JassasDepartment of Chemistry, Jamoum University College, Umm Al-Qura University, Makkah, Saudi Arabia.
Munirah M Al-RooqiDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Zainularifeen AbduljaleelScience and Technology Unit, Umm Al-Qura University, Makkah, Saudi Arabia.
Ahmed O BabalgithDepartment of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Hatem M AltassDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
Ziad MoussaDepartment of Chemistry, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.
Saleh A AhmedDepartment of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An efficient atom-economical synthetic protocol to access new imidazole-based

Indexed as

ADME and drug-likenessanticancer activitycomputational studiesimidazolemolecular dynamic simulationsmulticomponent reactionN-phenylbenzamide

Identifiers

PMID35155379
PMCPMC8830504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.